4-[2-(5-氯-2-甲氧基苯甲酰氨基)乙基]苯磺酰胺
5-Chloro-2-methoxy-N-(4-sulfamoylphenethyl)benzamide;N-(2-(4-sulfamoyl)phenyl)ethyl-5-chloro-2-methoxybenzamide;4-[2-(5-Chloro-2-Methoxy Benzamido)Ethyl]- Phenyl Sulphonamide;5-Chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-((5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonamide;4-[2-(5-Chloro-2-methoxy benzamido) ethyl] benzene sulfonamide;4-(2-methoxy-5-chlorobenzamidoethyl)benzenesulfonamide;4-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfamide;5-chloro-2-methoxy-n-(2-(4-sulfamoyl-phenyl)ethyl;N-(2-(4-(Aminosulfonyl)phenyl)ethyl)-5-chloro-2-methoxybenzamide;4-(5-CHLORO-2-METHOXYBENZAMIDOETHYL)BENZENESULFONAMIDE;4-[2-(5-CHLORO-2-METHOXY-BENZAMIDE)ETHYL]-BENZENESULPHONAMIDE;4-(2-(5-CHLORO-2-METHOXYBENZAMIDO)ETHYL)PHENYLSULFONAMIDE;4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)ETHYL]PHENYLSULPHONAMIDE;4-[2-(2-METHOXY-5-CHLOROBENZAMIDO)ETHYL]BENZENESULFONAMIDE;5-Chloro-2-methoxy-N-(4-sulfamoylphenethyl)-benzamide;4-[2-(5-Chloro-2-methoxybenzamido)ethyl]phenylsulfonamide;N-[2-[4-(Aminosulfonyl)phenyl]ethyl]-5-chloro-2-methoxybenzamide;Einecs 240-722-5;Glyburide USP RC A;Glyburide Related CoMpound A;NLRP3 Inflammasome InhibitorⅠ;NLRP3 Inflammasome Inhibitor I;GlibenclaMide (Glyburide) IMpurity A;5-Chloro-N-(p-sulfaMoylphenethyl)-o-anisaMide;5-Chloro-2- methoxy-N-[2-(4-sulphamoylphenyl;NLRP3-IN-2;16673-34-0;Oprea1_786605;BDBM50505856;JC121;SR-01000945190-1;Glibenclamide Imp. A (EP); Glyburide USP Related Compound A; Glyburide USP RC A; 5-Chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide; Glyburide Related Compound A; Glibenclamide Impurity A;16673-34-0 NLRP3i;SR-01000945190-2;C16H17ClN2O4S;Glibenclamide Impurity A;BCP13822;4-(2-(2-METHOXY-5-CHLOROBENZENE-1-CARBOXAMIDO)ETHYL)BENZENESULFONAMIDE;E79066;Z30856370;Glibenclamide impurity A, European Pharmacopoeia (EP) Reference Standard;A852220;AKOS000592467;HY-W011082;DTXSID1057660;UNII-8TF6P2NUB5;EN300-17995403;5-chloro-2-methoxy-N-[2-(4-sulfamoyl-phenyl) ethyl]-benzamide;FT-0637396;5-chloro-2-methoxy-N-(4-sulfamoylphenethyl_benzamide;CAS-16673-34-0;NS00005125;Benzamide, N-(2-(4-(aminosulfonyl)phenyl)ethyl)-5-chloro-2-methoxy-;8TF6P2NUB5;CS-W011798;O-ANISAMIDE, 5-CHLORO-N-(P-SULFAMOYLPHENETHYL)-;Tox21_113826;5-Chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide, 95%;EC 240-722-5;AS-16506;SCHEMBL8993421;CCG-268277;IDI1_008428;KVWWTCSJLGHLRM-UHFFFAOYSA-N;Benzamide, N-[2-[4-(aminosulfonyl)phenyl]ethyl]-5-chloro-2-methoxy-;MFCD00193756;s3680;W-107916;CHEMBL3188223;SB83716;NCGC00253706-02;4-[2-(5-Chloro-2-Methoxybenzamido)Ethyl]Benzenesulfonamide;NCGC00253706-01;IFLab1_000209;HMS1412J11;Glibenclamide impurity A (4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonamide);4-[2-(2-Methoxy-5-chlorobenzamido)ethyl]benzene sulfonamide;p-(2-{5-chloro-2-methoxybenzamido}ethyl)-benzene sulfonamide;Oprea1_846330;N-(2-(4-(Aminosulphonyl)phenyl)ethyl)-5-chloro-2-methoxybenzamide;DTXCID8031...